GELS
Gelteq Limited Ordinary Shares
NASDAQ: GELS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.66
+2.00% today
Updated 2026-05-01
Market cap
$6.91M
P/E ratio
—
P/S ratio
16.72x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Gelteq Limited Ordinary Shares (GELS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 3
Last 3 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.8%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-2.8%
2025-11-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-17 | $-0.34 | — | $1.00 | $0.97 | -2.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.34 | — | — | — |
| 2025-03-31 | $0.00 | $-0.38 | — | — | — |
| 2024-09-30 | $0.00 | $-0.14 | — | — | — |
Frequently asked questions
Has Gelteq Limited Ordinary Shares beaten earnings estimates?
Gelteq Limited Ordinary Shares has beaten Wall Street EPS estimates in 0 of its last 3 quarterly reports.
How does GELS stock react to earnings?
GELS stock has moved an average of -2.8% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.